Advertisement

The medicines belong to a class called long-acting beta 2-adrenergic agonists (LABA), which are long-acting bronchodilator medicines that help relax the muscles around the airways in the lungs.

Even though LABAs decrease the frequency of asthma attacks, they can make asthma attacks more severe when they do occur, the FDA said in a public health advisory released this week.

The advisory highlights a number of recommendations, including not to use LABAs as the first medicine to treat asthma or to treat wheezing that is getting worse. – (HealthDayNews)

Visit our Asthma Centre for more information.

May 2006
 

Print this article on

Rate this article Poor 1 2 3 4 5 Excellent